Literature DB >> 21899803

The effects of micronutrient-fortified complementary/replacement food on intestinal permeability and systemic markers of inflammation among maternally HIV-exposed and unexposed Zambian infants.

Anne Mullen1, Laura Gosset, Natasha Larke, Daniela Manno, Molly Chisenga, Lackson Kasonka, Suzanne Filteau.   

Abstract

The present randomised trial investigated the effects of feeding Zambian infants from 6 to 18 months old either a richly or basal micronutrient-fortified complementary/replacement food on gut integrity and systemic inflammation. Blood samples were obtained from all infants (n 743) at 6 and 18 months for the assessment of serum C-reactive protein (CRP) and α1-acid glycoprotein (AGP). A subsample of 502 infants, selected from the main cohort to include a larger proportion of infants with HIV-positive mothers, was assigned to lactulose/mannitol gut permeability tests. Lactulose:mannitol (L:M) ratio analyses were adjusted for baseline urinary L:M ratio, socio-economic status, mother's education, season of birth and baseline stunting, and stratified by maternal antenatal HIV status, child's sex, concurrent breast-feeding status and anaemia at baseline. There was no significant difference in geometric mean L:M ratio between the richly fortified and basal-fortified porridge arms at 12 months (0·47 (95 % CI 0·41, 0·55) v. 0·41 (95 % CI 0·34, 0·49); P = 0·16 adjusted). At 18 months, the richly fortified porridge group had a significantly higher geometric mean L:M ratio than the basal-fortified group (0·23 (95 % CI 0·19, 0·28) v. 0·15 (95 % CI 0·12, 0·19); P = 0·02 adjusted). This effect was evident for all stratifications, significantly among boys (P = 0·04), among the infants of HIV-negative mothers (P = 0·01), among the infants of HIV-negative mothers not concurrently breast-fed (P = 0·01) and among those who were not anaemic at baseline (P = 0·03). CRP, but not AGP, was positively associated with L:M ratio, but there were no significant effects of the diet on either CRP or AGP. In conclusion, a richly fortified complementary/replacement food did not benefit and may have worsened intestinal permeability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21899803      PMCID: PMC3776128          DOI: 10.1017/S0007114511003734

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  43 in total

1.  Effect of iron deficiency on small intestinal permeability in infants and young children.

Authors:  M Berant; M Khourie; I S Menzies
Journal:  J Pediatr Gastroenterol Nutr       Date:  1992-01       Impact factor: 2.839

2.  Automated enzymatic assays for the determination of intestinal permeability probes in urine. 1. Lactulose and lactose.

Authors:  C A Northrop; P G Lunn; R H Behrens
Journal:  Clin Chim Acta       Date:  1990-02-28       Impact factor: 3.786

Review 3.  Effect of iron supplementation on incidence of infectious illness in children: systematic review.

Authors:  Tarun Gera; H P S Sachdev
Journal:  BMJ       Date:  2002-11-16

4.  Impact of acute malaria on plasma concentrations of transferrin receptors.

Authors:  R Beesley; S Filteau; A Tomkins; T Doherty; H Ayles; A Reid; T Ellman; S Parton
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 May-Jun       Impact factor: 2.184

5.  Automated enzymatic assays for the determination of intestinal permeability probes in urine. 2. Mannitol.

Authors:  P G Lunn; C A Northrop; A J Northrop
Journal:  Clin Chim Acta       Date:  1989-08-15       Impact factor: 3.786

6.  Zinc supplementation tightens "leaky gut" in Crohn's disease.

Authors:  G C Sturniolo; V Di Leo; A Ferronato; A D'Odorico; R D'Incà
Journal:  Inflamm Bowel Dis       Date:  2001-05       Impact factor: 5.325

7.  Dietary supplementation with zinc and a growth factor extract derived from bovine cheese whey improves methotrexate-damaged rat intestine.

Authors:  Cuong D Tran; Gordon S Howarth; Peter Coyle; Jeffrey C Philcox; Allan M Rofe; Ross N Butler
Journal:  Am J Clin Nutr       Date:  2003-05       Impact factor: 7.045

8.  Iron-overload induces oxidative DNA damage in the human colon carcinoma cell line HT29 clone 19A.

Authors:  Michael Glei; Gladys O Latunde-Dada; Annett Klinder; Thomas W Becker; Uta Hermann; Klaus Voigt; Beatrice L Pool-Zobel
Journal:  Mutat Res       Date:  2002-08-26       Impact factor: 2.433

9.  Poor intestinal permeability in mildly stunted Nepali children: associations with weaning practices and Giardia lamblia infection.

Authors:  Rie Goto; Catherine Panter-Brick; Christine A Northrop-Clewes; Renu Manahdhar; Nhuchhe R Tuladhar
Journal:  Br J Nutr       Date:  2002-08       Impact factor: 3.718

10.  Intestinal inflammation measured by fecal neopterin in Gambian children with enteropathy: association with growth failure, Giardia lamblia, and intestinal permeability.

Authors:  David I Campbell; Graham McPhail; Peter G Lunn; Marinos Elia; Donald J Jeffries
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-08       Impact factor: 2.839

View more
  9 in total

Review 1.  Leaky gut: mechanisms, measurement and clinical implications in humans.

Authors:  Michael Camilleri
Journal:  Gut       Date:  2019-05-10       Impact factor: 23.059

2.  Zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age.

Authors:  Zohra S Lassi; Jaameeta Kurji; Cristieli Sérgio de Oliveira; Anoosh Moin; Zulfiqar A Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2020-04-08

3.  Associations between intestinal mucosal function and changes in plasma zinc concentration following zinc supplementation.

Authors:  K Ryan Wessells; Sonja Y Hess; Noel Rouamba; Zinewendé P Ouédraogo; Mark Kellogg; Rie Goto; Christopher Duggan; Jean-Bosco Ouédraogo; Kenneth H Brown
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

Review 4.  Environmental enteric dysfunction: an overview.

Authors:  Rosie J Crane; Kelsey D J Jones; James A Berkley
Journal:  Food Nutr Bull       Date:  2015-03       Impact factor: 2.069

5.  Cluster-randomised controlled trials of individual and combined water, sanitation, hygiene and nutritional interventions in rural Bangladesh and Kenya: the WASH Benefits study design and rationale.

Authors:  Benjamin F Arnold; Clair Null; Stephen P Luby; Leanne Unicomb; Christine P Stewart; Kathryn G Dewey; Tahmeed Ahmed; Sania Ashraf; Garret Christensen; Thomas Clasen; Holly N Dentz; Lia C H Fernald; Rashidul Haque; Alan E Hubbard; Patricia Kariger; Elli Leontsini; Audrie Lin; Sammy M Njenga; Amy J Pickering; Pavani K Ram; Fahmida Tofail; Peter J Winch; John M Colford
Journal:  BMJ Open       Date:  2013-08-30       Impact factor: 2.692

6.  A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy.

Authors:  Ashley Canipe; Takondwa Chidumayo; Meridith Blevins; Michael Bestawros; Jay Bala; Paul Kelly; Suzanne Filteau; Bryan E Shepherd; Douglas C Heimburger; John R Koethe
Journal:  BMC Infect Dis       Date:  2014-09-29       Impact factor: 3.090

Review 7.  Dietary strategies for improving iron status: balancing safety and efficacy.

Authors:  Andrew M Prentice; Yery A Mendoza; Dora Pereira; Carla Cerami; Rita Wegmuller; Anne Constable; Jörg Spieldenner
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

8.  Provision of small-quantity lipid-based nutrient supplements does not improve intestinal health among rural Malawian children.

Authors:  Zhifei Liu; Ulla Ashorn; Chilungamo Chingwanda; Kenneth Maleta; Lotta Hallamaa; Andrew Matchado; Emma Kortekangas; Kathryn G Dewey; Per Ashorn; Yue-Mei Fan
Journal:  Matern Child Nutr       Date:  2022-02-07       Impact factor: 3.660

9.  Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability.

Authors:  Béatrice Gleize; Franck Tourniaire; Laurence Depezay; Romain Bott; Marion Nowicki; Lionel Albino; Denis Lairon; Emmanuelle Kesse-Guyot; Pilar Galan; Serge Hercberg; Patrick Borel
Journal:  Br J Nutr       Date:  2012-12-11       Impact factor: 3.718

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.